Loading provider…
Loading provider…
Cardiovascular Disease Physician in San Diego, CA
NPI: 1124043948Primary Employer
Regents of the University of California
health.ucsd.edu
HQ Phone
Get M.D. Anthony's Phone Numberphone_androidMobile
Get M.D. Anthony's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1971 - 2027
NJ State Medical License
1969

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Cardiovascular Disease
University of California Davis Health
Fellowship • Cardiovascular Disease
1971 - 1973
USPHS Hospital
Residency • Internal Medicine
1969 - 1971
St Vincent Hospital
Internship • Transitional Year
1968 - 1969
Rutgers New Jersey Medical School
njms.rutgers.edu
Medical School
Until 1968
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 351 | 356 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 103 | 154 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 75 | 108 |
| 4 | 763763D radiographic procedure | 55 | 55 |
| 5 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 49 | 60 |
Authors: Smith, M D, Kwan, O L, DeMaria, A N
Journal: JAMA
Authors: Li, James, Reaven, Nancy L, Funk, Susan E, Lovett, Joseph E, DeMaria, Anthony N
Journal: Am J Cardiol
Publication Date: 2008-11-12
Authors: Rovai, D, Lubrano, V, Vassalle, C, Paterni, M, Marini, C, Kozakova, M, Castellari, M, Taddei, L, Trivella, M G, Distante, A, DeMaria, A N, L'Abbate, A
Journal: J Am Soc Echocardiogr
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: TQJ230
Lead Sponsor: CardioVascular BioTherapeutics, Inc.
Intervention / Treatment: COMBINATION_PRODUCT: Placebo, COMBINATION_PRODUCT: Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, COMBINATION_PRODUCT: Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose
Lead Sponsor: Longeveron Inc.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Longeveron Mesenchymal Stem Cells (LMSCs)